Table 2 Subject disposition (all randomized subjects).

From: Randomized multicenter trial to assess posterior capsule opacification and glistenings in two hydrophobic acrylic intraocular lenses

Category

HOYA-Alcon (N = 43)

Alcon-HOYA (N = 44)

Overall (N = 87)

n

(%)

n

(%)

n

(%)

Intent-to-treat population

43

(100.0)

44

(100.0)

87

(100.0)

Completer population

32

(74.4)

35

(79.5)

67

(77.0)

Per-protocol population

5

(11.6)

9

(20.5)

14

(16.1)

Withdrew from the study

11

(25.6)

9

(20.5)

20

(23.0)

Reason for early withdrawal adverse event

2

(4.7)

2

(4.5)

4

(4.6)

Voluntary withdrawal

3

(7.0)

2

(4.5)

5

(5.7)

Lost to follow-up

1

(2.3)

3

(6.8)

4

(4.6)

Physician’s decision

2

(4.7)

0

(0.0)

2

(2.3)

Death

3

(7.0)

1

(2.3)

4

(4.6)

Other

0

(0.0)

1

(2.3)

1

(1.1)

  1. Percentages are based on the number of randomized subjects in the sequence.
  2. The intent-to-treat population consists of all randomized subjects who have at least one IOL implanted.
  3. The completer population consists of all the ITT subjects who have both IOLs implanted with follow-up through the primary assessment time point.
  4. The per protocol population includes all subjects who are in the completer population with no significant protocol deviations.
Back to article page